Navigation Links
UC Davis begins $2.8 million in studies of agricultural nitrogen's impacts
Date:6/12/2009

is to the Agricultural Sustainability Institute, in collaboration with the University of California Agricultural Issues Center, Kearney Foundation for Soil Science, and the UC Sustainable Agriculture Research and Education Program.
  • $500,000 from the California Energy Commission and $350,000 from the David and Lucile Packard Foundation to Johan Six for new research on nitrous oxide emissions in various farming systems.
  • $300,000 from the California Air Resources Board to Will Horwath, professor in the UC Davis Department of Land, Air and Water Resources, for research on practical ways to reduce nitrous oxide emissions in California agriculture.
  • $150,000 from the California Department of Food and Agriculture's Fertilizer Research and Education Program to Horwath, Six and David Goorahoo, an assistant professor at the Center for Irrigation Technology at California State University, Fresno, to measure nitrous oxide emissions from cotton, corn and vegetable cropping systems.


    '/>"/>


  • Contact: Tom Tomich
    tptomich@ucdavis.edu
    530-574-2503
    University of California - Davis
    Source:Eurekalert

    Page: 1 2 3

    Related biology news :

    1. UC Davis bird-flu expert calls for changes in early-warning system
    2. UC Davis researchers discover how HIV turns food-poisoning into lethal infection
    3. UC Davis stem researchers demonstrate safety of gene therapy using adult stem cells
    4. UC Davis researcher leads climate-change discovery
    5. UC Davis researchers define characteristics, treatment options for XXYY syndrome
    6. UC Davis researchers discover new drug target for inflammatory disease
    7. UC Davis chemical ecologist wins major award
    8. UC Davis researchers discover a key to aggressive breast cancer
    9. UC Davis researchers discover Achilles heel in pancreatic cancer
    10. UC Davis researchers exploring gene therapy to fight AIDS
    11. UC Davis team refines cancer treatments to reduce potential nerve damage
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    Breaking Biology Technology:BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement 2BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5